Narval CC delivers clinical evidence | ResMed
Narval CC delivers clinical evidence
Healthcare professionals > Products > Narval CC delivers clinical evidence

Narval CC delivers clinical evidence

Narval CC™ packs custom-made comfort into a small, lightweight device, to make it easy for patients to be compliant and wear it regularly.

  • Small and discreet, lightweight and strong, 86% of patients wear their Narval CC every night.1

  • In a five-year ResMed ongoing clinical study, we found that patients used it on average 6.7 hours per night, and 6.7 nights per week.1

High compliance leads to high efficacy

  • Narval CC successfully stops loud snoring in almost 90% of patients who use it.1

  • Almost 80% of people who used Narval CC to fight their sleep apnoea — including those with more severe cases of OSA — saw their Apnoea-Hypopnea Index (AHI) decrease by more than 50%.1

  • Some two-thirds (66%) of users saw their AHI levels not only decrease, but fall below 10 — meaning their OSA had all but disappeared.1

Better health for patients and their partners

  • Two-thirds of Narval CC users who had been suffering from OSA stopped being tired during the day.1

  • 9 out of 10 patients no longer disturb their partners with their snoring.1 Indeed, 84% of partners are satisfied and regain high-quality sleep.2

Greater satisfaction leads to long-term use

  • 99% of people who use Narval CC are satisfied with their device.3

  • 77% of those who’ve tried Narval CC are still using it today.2



  1. Vecchierini MF &al. A custom-made mandibular repositioning device for obstructive sleep apnoea-hypopnoea syndrome: the ORCADES study. Sleep Med. 2016 Mar;19:131-40. doi: 10.1016. Two-year follow-up results. 
  2. A +A Healthcare study undertaken with 95 patients who wore Narval CC (Equinoxe in France) in 2011. 
  3. Since 01/01/2012, in the framework of a ‘satisfied or reimbursed’ offer by ResMed in France, only 56 patients out of 5103 asked to be reimbursed.